SCHEMBL7788355

SCHEMBL7788355

N=C(N)NN(c1cccc(C(CC(=O)O)NC(=O)c2ccc(OC(F)(F)F)cc2)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.47
ITGB3 P05106 2/20 0.44
ITGAV P06756 1/20 0.44
WDR5 P61964 1/20 0.42
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CXCR3 P49682 1/20 0.39
F10 P00742 3/20 0.38
ITGA2B P08514 1/20 0.38
TRPV1 Q8NER1 2/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KAT6A Q92794 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
ITGB1 P05556 1/20 0.38
ITGA4 P13612 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781180 0.90 EEF2K (0.46) ITGB3WDR5F10ITGA2BKCNQ3
SCHEMBL7785658 0.89 LMNA (0.44) ITGB3ITGAVLMNASMN1; SMN2F10
SCHEMBL7194899 0.89 ITGB3 (0.44) ITGB3ITGAVLMNASMN1; SMN2F10
SCHEMBL7790178 0.88 CTSA (0.41) MMP12ITGB3ITGAVF10ITGA2B
SCHEMBL7781206 0.87 ITGB3 (0.42) MMP12ITGB3F10ITGA2B
SCHEMBL7789969 0.87 CYP26A1 (0.42) ITGB3LMNASMN1; SMN2F10ITGA2B
SCHEMBL7788749 0.86 ITGB3 (0.44) ITGB3LMNASMN1; SMN2ITGA2BPRSS1
SCHEMBL7785607 0.84 LMNA (0.46) ITGB3ITGAVLMNASMN1; SMN2KAT6A
SCHEMBL7786214 0.83 S1PR3 (0.41) ITGB3ITGA2B
SCHEMBL7786241 0.82 CTSA (0.46) ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed